A review of the key issues associated with the commercialization of biobanks

Journal of Law and the Biosciences

Volumn 1, Issue 3, 2014, Pages 94-110

  Caulfield, Timothy ^a   Burningham, Sarah ^a   Joly, Yann ^b   Master, Zubin ^c   Shabani, Mahsa ^d   Borry, Pascal ^d   Becker, Allan ^e   Burgess, Michael ^a   Calder, Kathryn ^f   Critchley, Christine ^g   Edwards, Kelly ^h   Fullerton, Stephanie M ^h   Gottweis, Herbert ⁱ   Hyde Lay, Robyn ^a   Illes, Judy ^j   Isasi, Rosario ^b   Kato, Kazuto ^k   Kaye, Jane ^l   Knoppers, Bartha ^b   Lynch, John ^m   McGuire, Amy ^m   Meslin, Eric ⁿ   Nicol, Dianne ^o   O'Doherty, Kieran ^p   Ogbogu, Ubaka ^a   Otlowski, Margaret ^o   Pullman, Daryl ^q   Ries, Nola ^a   Scott, Chris ^r   Sears, Malcolm ^s   Wallace, Helen ^t   Zawati, Ma'n H ^b   more..

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ALBANY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF MANITOBA   (Canada)

^f CROSS CANCER INSTITUTE   (Canada)

^g SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k OSAKA UNIVERSITY   (Japan)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m Houston   (United States)

ⁿ INDIANA UNIVERSITY   (United States)

^o UNIVERSITY OF TASMANIA   (Australia)

^p UNIVERSITY OF GUELPH   (Canada)

^q MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^r STANFORD UNIVERSITY   (United States)

^s MCMASTER UNIVERSITY   (Canada)

^t GeneWatch UK   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901668893     PISSN: None     EISSN: 20539711     Source Type: Journal    
DOI: 10.1093/jlb/lst004     Document Type: Article

References (84)

1. R. Jean Cadigan, Neglected Ethical Issues in Biobank Management: results from a US Study, 9 Life Sci. Soc. Pol. 1 (2013)
2. Timothy Caulfield, Commercialization Creep,Pol.Options 20 (2012)
3. TaniaM.Bubela andTimothy Caulfield, Role and Reality: technology Transfer atCanadianUniversities, 28Trends Biotechnol. 447 (2010)
4. C.J.Murdoch andTimothy Caulfield, Commercialization, Patenting andGenomics: researcher Perspectives, 1 GenomeMed.22 (2009)
5. Manuel Crespo andHoussine Dridi, Intensification of University-Industry Relationships and Its Impact on Academic Research, 54 High Educ. 61 (2007);
6. Francis S. Collins, Reengineering Translational Science: the Time is Right, 3 Sci. Transl.Med. 90cm 17 (2011)
7. Elias A. Zerhouni et al., The Biomarkers Consortium: public and Private Sectors Working in Partnership to Improve the Public Health, 12 Oncologist 250 (2007);
8. Timothy Caulfield, Sustainability and the Balancing of the Health Care and Innovation Agendas: the Commercialization of Genetic Research, 66 Sask. Law Rev. 629 (2003)
9. Timothy Caulfield, Patents or Commercialization Pressure? A (Speculative) Search for the Right Target, 22 J. Law, Information And Science 122 (2012)
10. Genome Canada, 2012 Large-Scale Applied Research Project Competition, http://www.genomecanada.ca/en/portfolio/research/ 2012-competition.aspx (accessed 30 January 2014)
11. Henderson, supra note 2; Ingeborg Meijer, JordiMolas-Gallart and Pauline Mattsson, Networked Research Infrastructures and their Governance: the Case of Biobanking, 39 SPP 491 (2012)
12. Aaro Tupasela andNeil Stephens,TheBoom and Bust Cycle of Biobanking-ThinkingThrough the Life Cycle of Biobanks, 54.5 Croat.Med. J. 501 (2013)
13. Mylene Deschenes et al., Intellectual Property Rights in Publicly Funded Biobanks: much Ado about Nothing? 29.4 Nat. Biotechnol. 319 (2011);
14. David B. Resnik, Scientific Research and the Public Trust, 17 Sci. Eng. Ethics 399 (2011)
15. Zubin Master and David B. Resnik, Hype and Public Trust in Science, 19 Sci. Eng. Ethics 321 (2013)
16. Michael Clemence et al., Wellcome Trust Monitor Wave 2: Tracking Public Views on Science, Biomedical Research and Science Education (London, UK 2013)
17. Gillian Haddow et al., Tackling Community Concerns About Commercialisation And Genetic Research: a Modest Interdisciplinary Proposal, 64 Soc. Sci. Med. 272 (2007)
18. Christine R. Critchley, Public Opinion and Trust in Scientists: TheRole of the Research Context and the PerceivedMotivation of Stem Cell Researchers, 17PublicUnderst. Sci. 309 (2008)
19. Christine R. Critchley et al.,TheImpact of Commercialization on Public Perceptions of Stem Cell Research: Exploring Differences Across the Use of Induced Pluripotent Cells, Human and Animal Embryos, 9 Stem Cell Rev. 541 (2013)
20. Alan Petersen, SecuringOur GeneticHealth: Engendering Trust in UK Biobank, 27 Sociol. Health Illn. 271 (2005)
21. Tore Nilstun and Goran Hermeren, Human Tissue Samples and Ethics-Attitudes of the General Public in Sweden to Biobank Research, 9 Med. Health Care Philos. 81 (2006)
22. Timothy Caulfield et al., Biobanking, Consent, and Control: a Survey of Albertans on Key Research Ethics Issues, 10 Biopreserv. and Biobank. 433 (2012)
23. ZubinMaster et al., Cancer Patient Perceptions on the Ethical and Legal Issues Related to Biobanking, 6 BMCMed. Genomics 8 (2013)
24. A.A. Lemke et al., Public and Biobank Participant Attitudes Toward Genetic Research Participation and Data Sharing, 13 Public Health Genomics 368 (2010)
25. Christine Critchley, Dianne Nicol, Margaret Otlowski et al., Public Reaction to Direct to Consumer Online Genetic Tests: Comparing Attitudes, Trust and Intentions across Commercial and Conventional Providers (unpublished manuscript)
26. Kieran C. O'Doherty et al., Involving Citizens in the Ethics of Biobank Research: Informing Institutional Policy Through Structured Public Deliberation, 75 Soc. Sci. Med. 1604 (2012)
27. Dianne Nicol and Christine Critchley, Benefit Sharing and Biobanking in Australia, 21 Public Underst. Sci. 534 (2012)
28. Christine R. Critchley et al., Predicting Intention to Biobank: a National Survey, 22 Eur. J. Public Health 139 (2012)
29. Asa Kettis-Lindblad et al., Genetic Research and Donation of Tissue Samples to Biobanks. What Do Potential Sample Donors in the Swedish General Public Think? 16 Eur. J. Public Health 433 (2006)
30. Herbert Gottweis et al., Connecting the Public with Biobank Research: Reciprocity Matters, 12 Nat. Rev. Genet. 738 (2011)
31. Alexander Morgan Capron, Ethical Norms and the International Governance of Genetic Databases and Biobanks: Findings from an International Study, 19 Kennedy Inst. Ethic. J. 101 (2009)
32. James P. Evans et al., Genomics. Deflating the Genomic Bubble, 331 Science 861 (2011)
33. Jamie Doward, Sale of personal gene data condemned as 'unethical and dangerous', The Guardian, http://www. theguardian.com/science/2013/feb/17/gene-genetic-database-nhs-genewatch (accessed 17 February 2013)
34. Timothy Caulfield, Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales, 18 King's Law J. 209 (2007)
35. Zubin Master and David B Resnik, Incorporating Exclusion Clauses in Informed Consent for Biobanking, 22 Camb. Q. Healthc. Ethic. 203 (2013)
36. Jennifer Hochschild et al.,TechnologyOptimism or Pessimism:How Trust in Science Shapes Policy Attitudes Toward Genomic Science (Issues in Technology Innovation, Washington, DC 2012)
37. Michael Siegrist, The Influence of Trust and Perceptions of Risks and Benefits on the Acceptance of Gene Technology, 20 Risk Anal. 195 (2000)
38. Linus Johnsson et al., Patients' Refusal to Consent to Storage and Use of Samples in Swedish Biobanks: cross Sectional Study, 337BMJ a345 (2008)
39. Caulfield et al., supra note 18; Juli Murphy et al., Public Perspectives on Informed Consent for Biobanking, 99 Am. J. Public Health 2128 (2009)
40. Heather L. Walmsley, StockOptions, Tax Credits or Employment Contracts Please! The Value of Deliberative Public Disagreement About Human Tissue Donation, 73 Soc. Sci. Med. 209 (2011)
41. Kristin Solum Steinsbekk et al., We're Not in It for the Money-Lay People's Moral Intuitions on Commercial Use of 'Their' Biobank, 16Med. Health Care Philos. 151 (2013)
42. Eric M. Meslin et al., Health-Related Philanthropy: toward Understanding the Relationship between the Donation of the Body (and Its Parts) and Traditional Forms of Philanthropic Giving, 37NVSQ 44S (2008)
43. Elizabeth J. Horn et al., Engaging Research Participants and Building Trust, 15Genet. TestMol. Biomarkers 839 (2011)
44. Zubin Master et al., Biobanks, Consent and Claims of Consensus, 9 Nat. Methods 885 (2012)
45. Michelle M. Mello and Leslie E.Wolf, The Havasupai Indian Tribe Case-Lessons for Research Involving Stored Biologic Samples, 363 N. Engl. J.Med. 204 (2010)
46. Jay Root, Texas officials agree to destroy babies' blood samples after settling lawsuit, DALLAS MORNING NEWS (proposed 26 November 2010) http://www.dallasnews.com/ news/state/headlines/20091223-Texas-officials-agree-to-destroy-babies-1751.ece
47. Havasupai Tribe versus Arizona Board of Regents, 204 P.3d 1063, 220 Ariz. 214 (Ct. App. 2008)
48. Ricki Lewis, Is the Havasupai Indian Case a Fairy Tale?, Plos Blogs (proposed 15 August 2013) http://blogs.plos. org/dnascience/2013/08/15/is-the-havasupai-indian-case-a-fairy-tale
49. Mahsa Shabani, Heidi CarmenHoward and Pascal Borry, Commercialization of Population Biobanks: in Search of Lost Trust? (unpublished manuscript)
50. Justin E. Bekelman et al., Scope and Impact of Financial Conflicts of Interest in Biomedical Research: a Systematic Review, 289 JAMA 454 (2003)
51. Joel Lexchin et al., Pharmaceutical Industry Sponsorship and Research Outcome andQuality: systematic Review, 326BMJ 1167 (2003)
52. Mohit Bhandari et al., Association Between Industry Funding and Statistically Significant Pro-Industry Findings in Medical and Surgical Randomized Trials, 170 CMAJ 477 (2004)
53. Klaus Hoeyer, Trading in Cold Blood?, in TRUST IN BIOBANKING: DEALING WITH ETHICAL, LEGAL AND SOCIAL ISSUES IN AN EMERGING FIELD OF BIOTECHNOLOGY 21 (2012)
54. Rebecca Skloot, The Immortal Life of Henrietta Lacks, the Sequel, THE NEW YORK TIMES, (proposed 23March 2013) http://www.nytimes.com/2013/03/24/opinion/sunday/the-immortal-life-of-henrietta-lacks-thesequel. html;
55. Canadian Institutes of Health Research et al., Tri-Council Policy Statement: ethical Conduct for Research Involving Humans (2010), http://www.ethics.gc.ca/pdf/eng/tcps2/TCPS 2 FINAL Web.pdf
56. European Society of Human Genetics, Data Storage and DNA Banking for Biomedical Research, 11 Eur. J. Hum. Genet. S8 (2003)
57. John-Arne Skolbekken et al., NotWorth the Paper It's Written on? Informed Consent and Biobank Research in a Norwegian Context, 15 Critical Public Health 335 (2005)
58. Beatrice Godard et al., Community Engagement in Genetic Research: results of the First Public Consultation for the Quebec CARTaGENE Project, 10 Community Genet. 147 (2007)
59. Caplan, ArthurL., WhatNoOne KnowsCannotHurtYou: the Limits of Informed Consent in the Emerging World of Biobanking, inTheEthics of Research Biobanking 25 (Springer 2009)
60. Robert Mitchell andCatherine Waldby, National Biobanks: clinical Labor, Risk Production, and the Creation of Biovalue, 35 Sci. Technol. HumanValues 330 (2010)
61. Klaus Hoeyer, The Role of Ethics in Commercial Genetic Research: notes on the Notion of Commodification, 24Med. Anthropol. 45 (2005)
62. Sigrid Sterckx et al., 'Trust is Not Something You Can Reclaim Easily': patenting in the Field of Direct-to-Consumer Genetic Testing, 15 Genet.Med. 382 (2013)
63. Clarissa Allen, Yann Joly and Palmira Granados Moreno, Data Sharing, Biobanks and Informed Consent: a Research Paradox?, 7 Mcgill J. L. and Health 85 (2013)
64. Margaret F.A. Otlowski, Tackling Legal Challenges Posed by Population Biobanks: reconceptualising Consent Requirements, 20Med. Law Rev. 191 (2012)
65. StephanieMFullerton, Meeting the Governance Challenges of Next-Generation Biorepository Research, 2 Sci. TranslationalMed. 15cm3 (2010)
66. Kieran C. O'Doherty et al., From Consent to Institutions: designing Adaptive Governance for Genomic Biobanks, 73 Soc. Sci. Med. 367 (2011)
67. Bartha Maria Knoppers and Ruth Chadwick, Human Genetic Research: Emerging Trends in Ethics, 6 Nat. Rev. Genet. 75 (2005)
68. Jimmie Vaught et al., Biobankonomics: developing a Sustainable Business Model Approach for the Formation of a Human Tissue Biobank, 2011 J. Natl. Cancer Inst. Monographs 24 (2011)
69. Martin Yuille et al., The UK DNA Banking Network: a 'Fair Access' Biobank, 11 Cell Tissue Bank 241 (2010)
70. Jocelyn Kaiser, Human Genetics. Cash-Starved deCODE is Looking for a Rescuer for Its Biobank, 325 Science 1054 (2009)
71. Kevin Davies, Quebec's Genizon Biosciences Closes Its Doors (proposed 7 September 2011) http://www.bio-itworld.com/news/09/07/2011/Quebec-Genizon-Biosciences-closes-doors.html
72. Dan Vorhaus, Implications of Amgen/deCODE Deal for Genetic Testing Consumers, Genomics Law Report (proposed 10 December 2012) http://www.genomicslawreport.com/index.php/2012/12/10/ implications-of-amgendecode-deal-for-genetic-testing-consumers/
73. Monya Baker, Big Biotech Buys Iconic Genetics Firm, 492 Nature 321 (2012)
74. Genome Quebec, Public Notice: genizon Biosciences Inc. (proposed 12 December 2012) http://www.genomequebec.com/81-en.news-public-notice-genizon-biosciences-inc-.html
75. Catherine Heeney et al., Assessing the Privacy Risks of Data Sharing inGenomics, 14 PublicHealthGenomics 17 (2011)
76. DovGreenbaum et al., Genomics and Privacy: Implications of theNew Reality of ClosedData for the Field, 7 PLOS Comput. Biol. e1002278 (2011)
77. Yann Joly et al., Data Sharing in the Post-GenomicWorld: the Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO), 8 PLOS Comput. Biol. e1002549 (2012)
78. Peter H.J. Riegman et al., Biobanking for Better Healthcare, 2 Mol. Oncol. 213 (2008)
79. Kathinka Evers et al., What Are Your Views on Commercialization of Tissues for Research? 10 Biopreserv. and Biobank. 476 (2012)
80. Stefan Eriksson and Gert Helgesson, PotentialHarms, Anonymization, and the Right to Withdraw Consent to Biobank Research, 13 Eur. J. Hum. Genet. 1071 (2005)
81. Timothy Caulfield et al., Research Ethics Recommendations forWhole-Genome Research: consensus Statement, 6 PLOS Biol. e73 (2008)
82. Knoppers et al., supra note 2. Wylie Burke et al., Extending the Reach of Public Health Genomics: what Should Be the Agenda for Public Health in an Era of Genome-Based and 'personalized' Medicine?, 12 Genet. Med. 785 (2010)
83. Eric M. Meslin and Ibrahim Garba, Biobanking and Public Health: is a Human Rights Approach the Tie that Binds?, 130 Hum. Genet. 451 (2011)
84. Stacey Periera, Motivations and Barriers to Sharing Biological Samples: a Case Study, 3 J. Pers. Med. 102 (2013)